Sign in

You're signed outSign in or to get full access.

Kevin Schuyler

Chairman of the Board and Lead Independent Director at ADIAL PHARMACEUTICALS
Board

About Kevin Schuyler

Kevin Schuyler, CFA, is Adial’s non‑executive Chairman of the Board (since August 2022), Lead Independent Director, and has served as a director since April 2016; age 55 per the proxy’s director table . He is senior managing director at CornerStone Partners (institutional CIO office, ~$13B AUM) and previously worked at McKinsey & Company, Louis Dreyfus Corporation, and The Nature Conservancy; he graduated with honors from Harvard College and holds an MBA from UVA Darden; he is a member of the CFA Society of Washington, DC . The Board has determined he is independent under SEC/Nasdaq rules and is an “audit committee financial expert” per SEC definitions .

Past Roles

OrganizationRoleTenure/TimingCommittees/Impact
McKinsey & CompanyVarious positionsPrior to 2006Strategy/operations experience cited in biography
Louis Dreyfus CorporationVarious positionsPrior to 2006Global trading/finance exposure
The Nature ConservancyVarious positionsPrior to 2006Mission-driven organizational experience

External Roles

OrganizationRoleTenure/TimingCommittees/Impact
CornerStone Partners (Charlottesville, VA)Senior Managing DirectorSince 2006CIO office overseeing ~$13B AUM
Twin Vee PowerCats Co. (Nasdaq)DirectorCurrentDirector; marine OEM; no ADIL linkage disclosed
Forza X1, Inc. (Nasdaq)Director; Audit Committee ChairCurrentChairs audit committee
Sentara Martha Jefferson HospitalBoards and committeesCurrentCommunity healthcare governance roles
Margaret A. Cargill PhilanthropiesInvestment Committee memberCurrentInvestment oversight
US Endowment for Forestry and Communities; Stone Barns CenterBoard/committee rolesHistorical disclosures (2023 proxy)Additional nonprofit governance (prior-year proxy)

Board Governance

  • Board structure and class: Adial’s Board has six directors split into three staggered classes; Schuyler is a Class I director with his term expiring at the 2025 annual meeting per the 2024 proxy’s continuing director table .
  • Independence: The Board determined Schuyler is independent under SEC/Nasdaq rules .
  • Leadership and committee roles: Non‑executive Chairman; Lead Independent Director; Audit Committee Chair; member of the Nominating & Corporate Governance Committee .
  • Financial expertise: Designated “audit committee financial expert” by the Board .
  • Attendance: In 2023, the Board met 12 times; Audit (3), Compensation (2), Nominating & Governance (1), Pricing (3). Each incumbent director attended at least 75% of Board and committee meetings on which they served .
  • Anti‑hedging/pledging: Policy prohibits short‑term trading, short sales, hedging and pledging by directors and covered persons .

Fixed Compensation

ComponentAmount/PolicySource/Notes
Board Chair annual cash retainer$31,200Director fee schedule (effective for 2023)
Board member annual cash retainer$24,000Director fee schedule
Audit Committee Chair$16,000Director fee schedule
Audit Committee Member$8,000Director fee schedule
Compensation Committee Chair$11,000Director fee schedule
Compensation Committee Member$6,000Director fee schedule
Nominating & Governance Chair$8,000Director fee schedule
Nominating & Governance Member$4,000Director fee schedule
Schuyler – 2023 Cash Fees$48,000Director Compensation Table (FY2023)

Notes: Cash fees reflect role‑based retainers; Schuyler’s 2023 cash line was $48,000; committee mix and any proration drive variances from nominal schedules .

Performance Compensation

Grant/TypeGrant DateShares/Options (#)Exercise PriceVestingGrant Date FV ($)Notes
Annual Non‑Employee Director Option2023 (FY)12,219Schuyler’s FY2023 option award value per table
Annual Director OptionMar 25, 202412,000$1.35Over 3 yearsApplies to each non‑employee director (Schuyler included)
  • Plan mechanics: Equity awards under the 2017 Equity Incentive Plan; options are granted at closing market price on grant date; annual grants typically at regular meetings; no formal timing policy to benefit from MNPI .
  • Performance metrics: The plan permits performance goals for restricted stock or other equity, but the director awards disclosed are service‑vesting options; no director‑specific performance metrics are disclosed .
  • Say‑on‑pay and equity plan authorization: Shareholders approved increasing the 2017 Plan share reserve from 500,000 to 2,000,000 on Nov 12, 2024 .

Other Directorships & Interlocks

CompanyExchangeRoleCommittee RolesPotential Interlock/Conflict
Twin Vee PowerCats Co.NasdaqDirectorNone disclosed with ADIL; Board confirmed independence at ADIL
Forza X1, Inc.NasdaqDirectorAudit ChairNone disclosed with ADIL; Board confirmed independence at ADIL
  • Related‑party transactions oversight: Audit Committee reviews/approves related‑party transactions under Item 404 policy; apart from items disclosed elsewhere, the proxy notes no related‑party transactions during the two years ended Dec 31, 2023 or the current year as of filing; RPT policy and process detailed .

Expertise & Qualifications

  • Capital markets and investment management expertise; designated audit committee financial expert .
  • Education: Harvard College (honors), MBA from UVA Darden; CFA Society of Washington, DC member .
  • Governance: Prior and current audit chair roles; lead independent director experience .

Equity Ownership

ItemValueDetail/Breakdown
Shares outstanding (record date)6,405,781As of Sep 26, 2024
Schuyler – total beneficial ownership16,888<1% of outstanding
Ownership footnote details(i) Wife: 121 shares; warrants to acquire 78 shares @ $0.13 and 46 shares @ $190.86; (ii) Kevin William Schuyler 2020 Irrevocable Perpetuities Trust (wife as trustee): warrants to acquire 40 shares @ $0.13 and 345 shares @ $190.86; (iii) MVA 151 Investors, LLC (under Schuyler’s control): 5,768 shares; includes option to purchase 9,790 shares vesting within 60 days of Sep 26, 2024 (part of 19,823 total options)
  • Anti‑pledging/hedging: Company policy prohibits hedging and pledging by directors .

Fixed Compensation (Detail – FY2023 Director Table)

NameFees Earned or Paid in Cash ($)Stock Awards ($)Option Awards ($)Non‑Equity Incentive Plan Comp ($)All Other Comp ($)Total ($)
Kevin Schuyler, MBA, CFA48,00012,21960,219

Performance Compensation (Detail – Director Options)

NameOption Awards Outstanding as of 12/31/2023 (#)2024 Annual Option Grant (#)Exercise PriceVesting
Kevin Schuyler, MBA, CFA7,82312,000$1.35Over 3 years

Say‑on‑Pay & Shareholder Signals (2024)

Proposal (Nov 12, 2024)ForAgainstAbstainBroker Non‑Votes
Say‑on‑Pay (Advisory)528,590215,36515,5012,307,439
Equity Plan Share Reserve Increase528,590215,36515,5012,307,439

Note: The Board set say‑on‑pay frequency to every three years based on the 2024 advisory vote .

Governance Assessment

  • Strengths

    • Independent non‑executive Chair and Lead Independent Director; Audit Chair; SEC‑defined audit committee financial expert, supporting oversight of financial reporting, risk, and auditor independence .
    • Formal anti‑hedging/anti‑pledging policy enhances alignment and reduces risk of adverse optics from hedging/pledging .
    • Documented related‑party transaction review policy at Audit Committee level; proxy indicates no related‑party transactions during the covered periods aside from items disclosed, with process rigor described .
    • Board/committee attendance threshold met by all incumbent directors in 2023, indicating engagement; Board held 12 meetings with active committee cadence .
  • Watch items

    • Multi‑board and significant outside professional commitments (CornerStone Partners; two public boards) require ongoing monitoring of capacity; however, Board affirms independence and Schuyler’s service includes prior audit chair experience externally .
    • Ownership is modest (<1%); though anti‑pledge rules apply and director equity is largely in options with multi‑year vesting, which still aligns incentives to stock performance .
    • Director compensation mix for 2023 skews toward cash vs. equity (approx. $48k cash vs. $12.2k option value), a typical structure for micro/small‑cap boards but worth tracking for alignment as equity plan capacity expanded in 2024 .
  • No red flags disclosed regarding: legal proceedings involving directors/officers, or pledging/hedging (prohibited by policy). Related‑party items beyond those disclosed were not reported during the referenced periods; Tony Goodman’s COO services via Keswick are disclosed separately (not Schuyler) .

Other Notes (Board Composition and Tenure)

  • Classes and terms: Class I (Schuyler, Goodman) stands for election in 2025; Class II (Claiborne, Gilliland) in 2026; Class III (Anderson, Newman) re‑elected in 2024 for terms expiring 2027 .
  • Continuing directors’ ages and director‑since dates listed in proxy (Schuyler age 55; director since 2016) .

All data cited from Adial’s 2024 Definitive Proxy (DEF 14A) and related 8‑K filings: background/roles , committees/financial expert , independence , attendance , anti‑hedging/pledging , director compensation and fee schedule , beneficial ownership and footnotes , and shareholder vote outcomes and plan amendment (Nov 12, 2024) .